OSIR - Osiris Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201412/31/201312/31/2012
Total Revenue50,83525,6987,164
Cost of Revenue9,8866,8512,420
Gross Profit40,94918,8474,744
Operating Expenses
Research Development3,4144,3304,059
Selling General and Administrative44,51916,5287,038
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-6,984-2,011-6,353
Income from Continuing Operations
Total Other Income/Expenses Net-1,77141449
Earnings Before Interest and Taxes-8,755-1,597-6,304
Interest Expense---
Income Before Tax-8,755-1,597-6,304
Income Tax Expense97-994-37
Minority Interest---
Net Income From Continuing Ops-8,852-603-6,267
Non-recurring Events
Discontinued Operations-1,11843,063-5,318
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-9,97042,460-11,585
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-9,97042,460-11,585